Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

0
Player Avatar DonkeyJunk (24.69) Submitted: 5/5/2013 10:39:09 PM : Underperform Start Price: $38.41 BMY Score: -31.69

Stock with a PE of almost 50 in an on-average overvalued market due for a significant pullback. With a company this size, the increase in revenue would have to be astronomical to justify the price.

Featured Broker Partners


Advertisement